Argenica Therapeutics Ltd (AU:AGN) has released an update.
Argenica Therapeutics Ltd has announced the cancellation of 205,761 options due to expire on September 30, 2024, as a result of a mutual agreement with the holders. The announcement was made public on Wednesday, June 5, 2024. This move may impact investors holding or considering Argenica Therapeutics in their portfolios.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
